Wolfe Research Downgrades Boston Scientific Corporation (BSX) To Peer Perform

This marks the extremity of the firm’s bullish outlook connected the banal for 4 years, with the accommodation coming aft the institution said income maturation of its Watchman implant, which reduces the hazard of stroke, was slowing.

Wolfe Research present anticipates 7% integrated maturation for Boston Scientific Corporation (NYSE:BSX) successful 2027, according to TipRanks, which would enactment the stock terms successful the aboriginal $50s, astir the aforesaid level the banal is trading astatine currently.

Following the Watchman update, TD Cowen besides lowered its terms people connected the banal to $61 from $80, but maintained a Buy rating.

Despite caller expert revisions, BSX remains a Strong Buy based connected 27 analysts’ recommendations and has an mean stock terms upside of 70% arsenic of the adjacent connected May 29.

Boston Scientific Corporation (NYSE:BSX) is simply a planetary aesculapian exertion institution that manufactures and markets aesculapian devices that are utilized successful respective interventional aesculapian specialties.

While we admit the imaginable of BSX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Performing Defense Stocks So Far successful 2026 and 10 Stocks That Will Make You Rich Over the Next Decade.

Disclosure: None. Follow Insider Monkey connected Google News.